You are here: Industry Insights > china

News List

China pledged to promote Ayurvedic with Nepal biospectrumasia
August 18, 2017
Wang Yang pledged to cooperate with Nepal on further research in the sector of Ayurveda.
China’s Zai Lab files for $115M Nasdaq IPO to take Tesaro, Bristol-Myers cancer drugs through late-p fiercebiotech
August 17, 2017
A slice of the Zai Lab IPO haul is earmarked for trials of Tesaro's niraparib.
Half Brine, Half Flame: Two Different Worlds of “Magic Scissors” en-cphi.cn
August 11, 2017
Scientists from China, South Korea and the U.S. succeeded in safe correction of the gene mutation in early human embryos that results in hypertrophic cardiomyopathy by using CRISPR/Cas9 genome editing technique.
Hangzhou Just Biotherapeutics, Ltd. Secures Closing of Series B Financing en-cphi.cn
August 09, 2017
Company receives $57M to Further Advance Biologics Development and Clinical Trials
SGS Expands Site's Capacity at Lincolnshire contractpharma
August 09, 2017
The expension doubles the site’s current capacity for a range of services
MSD’s “Biosimilar” of Lantus Obtained Tentative Approval of FDA, Gan & Lee Pharmaceuticals to Snatch en-cphi.cn
August 04, 2017
MSD’s LUSDUNA Nexvue (insulin glargine injection, 100 units/ml) has recently received FDA’s tentative approval for treating Type 1 and Type 2 diabetes.
India set to block $1.3 bn Gland Pharma-Fosun deal : Report expressbpd
August 02, 2017
The deal was announced last July when Shanghai Fosun agreed to buy an 86 per cent stake in KKR & Co-backed Gland Pharma
WuXi's Pharmaceutical Development Services Division Merges with STA en-cphi.cn
July 31, 2017
STA Pharmaceutical Co., Ltd. (STA) announces that it has merged with WuXi AppTec's Pharmaceutical Development Services (PDS) division.
New Findings in Ovarian Cancer Treatment: Another TCM Atractylodes Macrocephala Promoting the Nation en-cphi.cn
July 28, 2017
As one of the most common causes of death among cancers of females, the ovarian cancer has a case fatality rate ranking first in gynecologic malignant tumors.
Years after the Restriction Order of Antibiotics Usage, the Antibiotic Market Reshuffled to Enter th en-cphi.cn
July 28, 2017
Under the restriction order of antibiotics usage, many antibiotics have been listed in the scope of “restricted drugs” and “special drugs”, and the market development has been subject to large restrictions, with sales shrinking and market reshuffled.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page